ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

EYE Q2 Deep Dive: Brand Revamp, Pricing Actions, and Managed Care Drive Results

EYE Cover Image

Optical retailer National Vision (NYSE: EYE) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.7% year on year to $486.4 million. The company’s full-year revenue guidance of $1.95 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.18 per share was 31.1% above analysts’ consensus estimates.

Is now the time to buy EYE? Find out in our full research report (it’s free).

National Vision (EYE) Q2 CY2025 Highlights:

  • Revenue: $486.4 million vs analyst estimates of $469.8 million (7.7% year-on-year growth, 3.5% beat)
  • Adjusted EPS: $0.18 vs analyst estimates of $0.14 (31.1% beat)
  • Adjusted EBITDA: $46.17 million vs analyst estimates of $40.73 million (9.5% margin, 13.4% beat)
  • The company slightly lifted its revenue guidance for the full year to $1.95 billion at the midpoint from $1.94 billion
  • Management raised its full-year Adjusted EPS guidance to $0.66 at the midpoint, a 4.8% increase
  • Operating Margin: 3.4%, up from 0.1% in the same quarter last year
  • Locations: 1,240 at quarter end, up from 1,216 in the same quarter last year
  • Same-Store Sales rose 5.9% year on year (2.4% in the same quarter last year)
  • Market Capitalization: $1.80 billion

StockStory’s Take

National Vision’s second quarter results received a negative market reaction, despite the company surpassing Wall Street expectations for revenue and non-GAAP earnings. Management attributed these results to ongoing pricing actions, improvements in product assortment, and initiatives aimed at modernizing the customer experience. CEO Alex Wilkes highlighted the “significant transformation and accelerated growth” underway, emphasizing that refreshed branding and strategic investments in digital capabilities have started to show tangible benefits, particularly in managed care and product mix.

Looking forward, the company’s updated guidance reflects confidence in ongoing digital and marketing initiatives, though management remains cautious given macroeconomic uncertainty. Wilkes noted that the launch of a new CRM system and a revitalized America’s Best brand are expected to enhance personalized marketing and customer retention. CFO Chris Laden stated that while prior pricing actions are expected to support margins, the company is not assuming additional price increases in its outlook until more data becomes available. Management believes these efforts will help sustain growth while maintaining operational discipline.

Key Insights from Management’s Remarks

Management cited higher average ticket size, strategic pricing, and a revitalized brand as primary contributors to the quarter’s outperformance versus expectations, alongside ongoing managed care momentum and cost discipline.

  • Managed care expansion: Growth in managed care customers was a key contributor, with the cohort showing low double-digit comp growth and higher average transaction sizes compared to cash pay customers. Management is targeting a 50% mix for managed care, viewing it as a long-term growth lever.

  • Product mix and premiumization: The introduction of new designer frames and an updated assortment led more customers—both managed care and cash pay—to trade up to higher-priced products. Wilkes reported that premium collections like Lam and Ted Baker are “turning at above average rates,” validating the company’s upmarket shift.

  • Brand and marketing transformation: The launch of refreshed branding for National Vision and America’s Best is central to the company’s strategy. Management is investing in digital marketing and a new CRM platform to drive more targeted, personalized outreach, aiming to attract higher-income demographics and improve customer retention.

  • Store fleet optimization: The company continued to open new locations while closing underperforming stores, focusing on profitability and alignment with strategic priorities. Laden emphasized that closures were based on profitability, doctor availability, and demographic shifts, with no significant changes expected in the pace of closures.

  • Eyeglass World improvements: Leadership changes and a new doctor model in Florida drove improved performance at Eyeglass World, which saw its best first-half results since 2021. Management plans further modernization and strategic investments in this banner moving forward.

Drivers of Future Performance

National Vision’s outlook is driven by expanded managed care penetration, enhanced digital marketing, and the impact of recent pricing and assortment changes, balanced by macroeconomic uncertainty.

  • Digital and CRM rollout: The company expects its new CRM platform and digital marketing initiatives to drive improved customer engagement and retention, particularly among higher-income and managed care segments. Management will monitor the effectiveness of these tools before incorporating further benefits into guidance.

  • Margin focus and cost optimization: Management is prioritizing operating margin expansion through ongoing assortment upgrades, efficiency initiatives, and partnership with Accenture on cost optimization. Guidance incorporates expected gross margin gains but remains cautious on further pricing actions until more consumer data is available.

  • Macroeconomic caution and consumer mix: Management is taking a prudent approach to guidance for the second half, citing ongoing macroeconomic noise and uncertainty about consumer demand. The company does not expect significant changes in traffic trends and is closely watching the evolving tariff environment, which is now expected to have a minimal impact due to regulatory changes and mitigation strategies.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be watching (1) the impact of the new CRM and digital marketing initiatives on customer acquisition and retention, (2) further expansion and performance of managed care and premium product segments, and (3) the pace and effectiveness of store optimization efforts, including closures and new openings. Progress on cost control initiatives and the ability to drive margin expansion will also be key markers.

National Vision currently trades at $22.79, down from $24.83 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+0.00 (0.00%)
AAPL  278.85
+0.00 (0.00%)
AMD  217.53
+0.00 (0.00%)
BAC  53.65
+0.00 (0.00%)
GOOG  320.12
+0.00 (0.00%)
META  647.95
+0.00 (0.00%)
MSFT  492.01
+0.00 (0.00%)
NVDA  177.00
+0.00 (0.00%)
ORCL  201.95
+0.00 (0.00%)
TSLA  430.17
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.